Primary care clinicians focus on acute migraine management, despite the chronic nature of this neurological disease.

Remote neuromodulation may offer safe, effective relief for a range of migraine types, including those with aura and chronic ...

Around five million Australians suffer from migraines, with women three times more likely to be affected than men ...

Dealing with a headache or migraine is never fun, but doctors and dietitians say these foods may offer some relief.

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

Patients with migraine discontinued treatment less often with atogepant and experienced a greater reduction in mean monthly ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

(HealthDay News) — For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and Migraine Disability Assessment (MIDAS) scores, according ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...